Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoekstra

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Investigational New Drugs|August 2, 2003
Clinical trial design for target specific anticancer agentsRonald Hoekstra, Jaap Verweij, Ferry A L M Eskens
Journal of Surgical Oncology|April 1, 2018
Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomesMerel Lubbers, Marc J van Det, Mariska J Kreuger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Successful treatment of renal cell carcinoma with sorafenib after effective but hepatotoxic sunitinib exposureHans M Westgeest, Nielka P van Erp, Richard J Honeywell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancerMarco B Polee, Alex Sparreboom, Ferry A L M Eskens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
A phase I pharmacokinetic and pharmacodynamic study of the farnesyl transferase inhibitor BMS-214662 in combination with cisplatin in patients with advanced solid tumorsHelen J Mackay, Ronald Hoekstra, Ferry A L M Eskens, et al.
Journal of the National Cancer Institute|June 26, 2024
Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohortTom van den Ende, Nicolien C de Clercq, Mark Davids, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignanciesRonald Hoekstra, Herlinde Dumez, Ferry A L M Eskens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancerRonald Hoekstra, Filip Y F L de Vos, Ferry A L M Eskens, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2024
Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal CancerMerel J M van Velzen, Marieke Pape, Mirjam A G Sprangers, et al.
Medicine and Science in Sports and Exercise|December 11, 2023
Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after DiagnosisKarel C Smit, Jeroen W G Derksen, Rebecca K Stellato, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Investigational New Drugs|August 2, 2003
Clinical trial design for target specific anticancer agentsRonald Hoekstra, Jaap Verweij, Ferry A L M Eskens
Journal of Surgical Oncology|April 1, 2018
Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomesMerel Lubbers, Marc J van Det, Mariska J Kreuger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Successful treatment of renal cell carcinoma with sorafenib after effective but hepatotoxic sunitinib exposureHans M Westgeest, Nielka P van Erp, Richard J Honeywell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancerMarco B Polee, Alex Sparreboom, Ferry A L M Eskens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
A phase I pharmacokinetic and pharmacodynamic study of the farnesyl transferase inhibitor BMS-214662 in combination with cisplatin in patients with advanced solid tumorsHelen J Mackay, Ronald Hoekstra, Ferry A L M Eskens, et al.
Journal of the National Cancer Institute|June 26, 2024
Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohortTom van den Ende, Nicolien C de Clercq, Mark Davids, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignanciesRonald Hoekstra, Herlinde Dumez, Ferry A L M Eskens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancerRonald Hoekstra, Filip Y F L de Vos, Ferry A L M Eskens, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2024
Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal CancerMerel J M van Velzen, Marieke Pape, Mirjam A G Sprangers, et al.
Medicine and Science in Sports and Exercise|December 11, 2023
Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after DiagnosisKarel C Smit, Jeroen W G Derksen, Rebecca K Stellato, et al.
Pageof 2